Persistent paresis of the facialis muscle after European adder (Vipera berus) bite on the forehead

Toxicon

Volumn 40, Issue 11, 2002, Pages 1627-1629

  Weinelt, Wolfgang ^a   Sattler, Raimund Wolfgang ^b   Mebs, Dietrich ^c  

^a Bundeswehrkrankenhaus Berlin   (Germany)

^b Krankenhaus Soltau   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Adder bite; Muscle paresis; Paresis; Snakebite

Indexed keywords

BUPRENORPHINE; CEPHALOSPORIN; CORTICOSTEROID; DIAZEPAM; SNAKE VENOM;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; EDEMA; FACE MUSCLE; FOREHEAD; HUMAN; MALE; PARESIS; PETECHIA; PRIORITY JOURNAL; PTOSIS; SNAKEBITE;

ADULT; ANIMALS; DIAGNOSIS, DIFFERENTIAL; EDEMA; FACIAL PARALYSIS; FOREHEAD; HUMANS; MALE; MILITARY PERSONNEL; NEUROLOGIC EXAMINATION; SNAKE BITES; VIPERIDAE;

SERPENTES; VIPERA; VIPERA BERUS;

EID: 0036843146     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(02)00167-8     Document Type: Article

References (17)

1. Antonini G., Rasura M., Conti G., Mattia C. Neuromuscular paralysis in Vipera aspis envenomation: pathogenic mechanisms. J. Neurol. Neurosurg. Psychiatry. 54:1991;187.
2. Beer E., Putorti F. Dysphonia, an uncommon symptom of systemic neurotoxic envenomation by Vipera aspis bite. Report of two cases. Toxicon. 36:1998;697-701.
3. Bouquier J.J., Guibert J., Dupont C.L., Umdenstock R. Les piqures de vipère chez l'enfant. Etude de 43 cas. Arch. Fr. Pediatr. 31:1974;285-296.
4. Campbell C.H. Myotoxic paralysis and haemolytic anaemia due to king brown snake bite. Aust. NZ J. Med. 14:1984;169.
5. De Haro L., Choumet V., Robbe-Vincent A., Bon C., Jouglard J., Perringue C. Des vipères neurotoxiques dans les Alpes Maritimes? Rev. Practicien. 265:1994;20-23.
6. Gonzales D. Snakebite problems in Europe. Tu A.T., Handbook of Natural Toxins. vol. 5:1991;687-751 Marcel Dekker, New York.
7. Komori Y., Nikai T., Sugihara H. Comparison of the lethal components in Vipera aspis and Vipera aspis zinnikeri venom. J. Nat. Toxins. 7:1998;101-108.
8. 2 from the venom of the common viper, Vipera berus berus. Biochim. Biophys. Acta. (1157):1993;81-85.
9. 2 from Vipera ammodytes ammodytes venom. Arch. Int. Pharmacodyn. 268:1984;313-324.
10. Persson H., Irrestedt B. A study of 136 cases of adder bite treated in Swedish hospitals during one year. Acta Med. Scand. 210:1981;433-439.
11. Persson H., Karlson-Stiber C. Clinical features and principles of treatment of envenoming by European vipers. Bon C., Goyffon M., Envenoming and their Treatment. 1996;281-292 Fondation Marcel Merieux, Lyon.
12. Pozio E. Venomous snake bite in Italy: epidemiological and clinical aspects. Trop. Med. Parasitol. 39:1988;62-66.
13. Re G., Trisolino G., Miglio F. Eye muscle paralysis after Vipera aspis envenomation. J. Accid. Emerg. Med. 16:1999;458.
14. Reid H.A. Adder bites in Britain. Br. Med. J. ii:1976;153-156.
15. 2 from Vipera ammodytes ammodytes venom. Biochim. Biophys. Acta. 828:1985;306-312.
16. Scholer H., Wüthrich W. Klinische und toxikologische Probleme der Bisse durch Giftschlangen. Schweiz. Med. Wschr. 100:1970;1761-1766.
17. Sutherland S.K., Tibballs J. Australian Animal Toxins. 2001;Oxford University Press, Melbourne, Australia.